287 related items for PubMed ID: 28862548
1. Reoperation for growth hormone-secreting pituitary adenomas: report on an endonasal endoscopic series with a systematic review and meta-analysis of the literature.
Almeida JP, Ruiz-Treviño AS, Liang B, Omay SB, Shetty SR, Chen YN, Anand VK, Grover K, Christos P, Schwartz TH.
J Neurosurg; 2018 Aug; 129(2):404-416. PubMed ID: 28862548
[Abstract] [Full Text] [Related]
2. Management of growth hormone-secreting pituitary adenomas causing acromegaly: a practical review of surgical and multimodal management strategies for neurosurgeons.
Cheok SK, Carmichael JD, Zada G.
J Neurosurg; 2024 May 01; 140(5):1285-1294. PubMed ID: 37948697
[Abstract] [Full Text] [Related]
3. A single-center experience of transsphenoidal endoscopic surgery for acromegaly in 73 patients: results and predictive factors for remission.
Unal TC, Aydoseli A, Ozgen U, Dolas I, Sabanci PA, Aras Y, Ozturk M, Ozata MS, Gul N, Kubat Uzum A, Mutlu U, Bilgic B, Saka E, Yarman S, Sencer A.
Br J Neurosurg; 2024 Jun 01; 38(3):648-653. PubMed ID: 34241568
[Abstract] [Full Text] [Related]
4. The multimodal management of GH-secreting pituitary adenomas: predictive factors, strategies and outcomes.
Buliman A, Tataranu LG, Ciubotaru V, Cazac TL, Dumitrache C.
J Med Life; 2016 Jun 01; 9(2):187-92. PubMed ID: 27453753
[Abstract] [Full Text] [Related]
5. Endoscopic endonasal approach for acromegaly: surgical outcomes using 2018 consensus criteria for remission.
de Carvalho Cavalcante RA, Vieira LA, Peres LFA, Zaccariotti AJ, de Sousa Alencar H, Jatene EM, Camargo LA, Dias Rodrigues ML.
Arch Endocrinol Metab; 2023 Jun 19; 67(6):e000650. PubMed ID: 37364152
[Abstract] [Full Text] [Related]
6. Long-term control of acromegaly after pituitary surgery in South-Eastern Norway.
Falch CM, Dupont AK, Olarescu NC, Wiedmann M, Dahlberg D, Bollerslev J, Berg-Johnsen J, Heck A.
Acta Neurochir (Wien); 2023 Oct 19; 165(10):3003-3010. PubMed ID: 37665404
[Abstract] [Full Text] [Related]
7. Determinants of immediate and long-term remission after initial transsphenoidal surgery for acromegaly and outcome patterns during follow-up: a longitudinal study on 659 patients.
Guo X, Zhang R, Zhang D, Wang Z, Gao L, Yao Y, Deng K, Bao X, Feng M, Xu Z, Yang Y, Lian W, Wang R, Ma W, Xing B.
J Neurosurg; 2022 Sep 01; 137(3):618-628. PubMed ID: 35171834
[Abstract] [Full Text] [Related]
8. Long-term outcomes of transsphenoidal surgery for management of growth hormone-secreting adenomas: single-center results.
Asha MJ, Takami H, Velasquez C, Oswari S, Almeida JP, Zadeh G, Gentili F.
J Neurosurg; 2019 Oct 11; 133(5):1360-1370. PubMed ID: 31604330
[Abstract] [Full Text] [Related]
9. Endoscopic endonasal lateral transellar approach for growth hormone-secreting adenomas with cavernous sinus invasion: Technical note and surgical results.
Gómez-Amador JL, Martínez-Anda JJ, Guerrero-Suarez PD, Rosales-Amaya AM, Delgado-Arce JC, Guerrero-López DA.
Neurocirugia (Astur : Engl Ed); 2020 Jul 17. PubMed ID: 32690399
[Abstract] [Full Text] [Related]
10. Endoscopic Endonasal Transsphenoidal Surgery for the Resection of Pituitary Adenomas: A Prime Candidate for a Shortened Length of Stay Enhanced Recovery after Surgery Protocol? A Systematic Review.
Shah H, Slavin A, Botvinov J, O'Malley GR, Sarwar S, Patel NV.
World Neurosurg; 2024 Jun 17; 186():145-154. PubMed ID: 38552787
[Abstract] [Full Text] [Related]
11. Cytodifferentiation of pituitary tumors influences pathogenesis and cavernous sinus invasion.
Asmaro K, Zhang M, Rodrigues AJ, Mohyeldin A, Vigo V, Nernekli K, Vogel H, Born DE, Katznelson L, Fernandez-Miranda JC.
J Neurosurg; 2023 Nov 01; 139(5):1216-1224. PubMed ID: 37119095
[Abstract] [Full Text] [Related]
12. Comparative Efficacy of Transsphenoidal and Transcranial Approaches for Treating Tuberculum Sellae Meningiomas: A Systematic Review and Meta-Analysis.
Agosti E, Alexander AY, Antonietti S, Zeppieri M, Piazza A, Panciani PP, Fontanella MM, Pinheiro-Neto C, Ius T, Peris-Celda M.
J Clin Med; 2024 Apr 18; 13(8):. PubMed ID: 38673630
[Abstract] [Full Text] [Related]
13. Headache Improvement Following Endoscopic Resection of Pituitary Adenomas.
Delport R, King J, Castle-Kirszbaum M, Goldschlager T, Caputo C, Wang YY.
World Neurosurg; 2023 Aug 18; 176():e456-e461. PubMed ID: 37277024
[Abstract] [Full Text] [Related]
14. Preoperative and postoperative blood testosterone levels in patients with acromegaly: a prospective study.
Zhang D, Guo X, Feng M, Bao X, Deng K, Yao Y, Lian W, Xing B, Wang H.
Front Endocrinol (Lausanne); 2023 Aug 18; 14():1259529. PubMed ID: 37886642
[Abstract] [Full Text] [Related]
15. Outcomes in pituitary adenoma causing acromegaly following endoscopic endonasal transsphenoidal surgery.
Chhabra R, Kumar A, Virk RS, Dutta P, Ahuja C, Mohanty M, Dhandapani S.
J Neurosci Rural Pract; 2022 Aug 18; 13(4):696-704. PubMed ID: 36743751
[Abstract] [Full Text] [Related]
16. Growth hormone tumor histological subtypes predict response to surgical and medical therapy.
Kiseljak-Vassiliades K, Carlson NE, Borges MT, Kleinschmidt-DeMasters BK, Lillehei KO, Kerr JM, Wierman ME.
Endocrine; 2015 May 18; 49(1):231-41. PubMed ID: 25129651
[Abstract] [Full Text] [Related]
17. Predictors for Remission after Transsphenoidal Surgery in Acromegaly: A Dutch Multicenter Study.
Coopmans EC, Postma MR, Wolters TLC, van Meyel SWF, Netea-Maier R, van Beek AP, Neggers SJCMM.
J Clin Endocrinol Metab; 2021 May 13; 106(6):1783-1792. PubMed ID: 33544833
[Abstract] [Full Text] [Related]
18. Integrative clinical, hormonal, and molecular data associate with invasiveness in acromegaly: REMAH study.
Sampedro-Nuñez M, Herrera-Martínez AD, Ibáñez-Costa A, Rivero-Cortés E, Venegas E, Robledo M, Martínez-Hernández R, García-Martínez A, Gil J, Jordà M, López-Fernández J, Gavilán I, Maraver S, Marqués-Pamies M, Cámara R, Fajardo-Montañana C, Valassi E, Dios E, Aulinas A, Biagetti B, Álvarez Escola C, Araujo-Castro M, Blanco C, Paz M, Villar-Taibo R, Álvarez CV, Gaztambide S, Webb SM, Castaño L, Bernabéu I, Picó A, Gálvez MÁ, Soto-Moreno A, Puig-Domingo M, Castaño JP, Marazuela M, Luque RM, REMAH investigators
.
Eur J Endocrinol; 2024 Jun 05; 190(6):421-433. PubMed ID: 38701338
[Abstract] [Full Text] [Related]
19. A Novel Preoperative Score to Predict Long-Term Biochemical Remission in Patients with Growth-Hormone Secreting Pituitary Adenomas.
Cohen-Cohen S, Rindler R, Botello Hernandez E, Donegan D, Erickson D, Meyer FB, Atkinson JL, Van Gompel JJ.
World Neurosurg; 2024 Feb 05; 182():e882-e890. PubMed ID: 38123128
[Abstract] [Full Text] [Related]
20. Outcomes of Endoscopic Transsphenoidal Approach for More Aggressive Pediatric Pituitary Adenomas: Early- and Late-Term Results from a Single Center Experience.
Caklili M, Yilmaz E, Duman Ozturk S, Uzuner A, Yildirim P, Cizmecioglu Jones FM, Tas A, Cabuk B, Anik I, Ceylan S.
World Neurosurg; 2023 Aug 05; 176():e623-e633. PubMed ID: 37271260
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
